High-Throughput Proteomic Analysis Services

High-throughput proteomic analysis will be conducted on bone marrow plasma samples derived from patients with myelodysplastic syndromes using the proprietary Olink Explore HT platform to generate standardized, high-resolution protein expression datasets. The goal is to facilitate biomarker discovery and in-depth analysis of disease-associated molecular pathways, enabling improved understanding of disease mechanisms and potential therapeutic targets. All work must adhere to strict quality control protocols to ensure data reproducibility and compatibility across samples, with results delivered in a format suitable for downstream computational and statistical analysis. The contract is issued under NAICS code 541380 as a subcontract by the National Institutes of Health through the Department of Health and Human Services, with performance taking place in Bethesda, Maryland, at a zip code of 20892. The opportunity was posted on June 30, 2026, and responses are due by July 9, 2026, at 1:00 PM. While no set-aside classification is specified, the work requires specialized expertise in advanced proteomic technologies and experience with clinical biospecimens from hematological disorders. The successful vendor will be expected to deliver fully processed, annotated proteomic datasets aligned with predefined analytical standards and timelines.